Atrium Therapeutics Inc.
RNA | NASDAQ
$8.32
-$0.36 (-4.15%)
At close: Nov 5, 2026, 4:00 PM ET
$8.32
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 4:10 PM ET
90-Day Net Volume
$0.00
90-Day Activity
0 Buys / 0 Sales
All-Time Net Volume
$0.00
Total Filings
8
| Name | Transaction Date | Transaction Type | Shares | Price | Value |
|---|---|---|---|---|---|
Younis Husam Chief Scientific Officer | Sep 18, 2026 | F-InKind Common Stock | 11,216 | 8.95 | $100,383 |
Hughes Steven George Chief Medical Officer | Sep 18, 2026 | F-InKind Common Stock | 21,459 | 8.95 | $192,058 |
Flanagan W. Michael Director | Sep 18, 2026 | F-InKind Common Stock | 22,812 | 8.95 | $204,167 |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove RNA